Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Forsberg

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 23, 2023
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiersLars Forsberg, Tim Spelman, Pernilla Klyve, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2024
Biological validation of peak-width of skeletonized mean diffusivity as a VCID biomarker: The MarkVCID ConsortiumAlison M Luckey, Saptaparni Ghosh, Chen-Pin Wang, et al.
Neurology|October 6, 2021
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple SclerosisSteve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2020
COVID-19 in people with multiple sclerosis: A global data sharing initiativeLiesbet M Peeters, Tina Parciak, Clare Walton, et al.
Frontiers in Neurology|January 8, 2024
Predictors of treatment switching in the Big Multiple Sclerosis Data NetworkTim Spelman, Melinda Magyari, Helmut Butzkueven, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 23, 2023
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiersLars Forsberg, Tim Spelman, Pernilla Klyve, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 21, 2024
Biological validation of peak-width of skeletonized mean diffusivity as a VCID biomarker: The MarkVCID ConsortiumAlison M Luckey, Saptaparni Ghosh, Chen-Pin Wang, et al.
Neurology|October 6, 2021
Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple SclerosisSteve Simpson-Yap, Edward De Brouwer, Tomas Kalincik, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 15, 2020
COVID-19 in people with multiple sclerosis: A global data sharing initiativeLiesbet M Peeters, Tina Parciak, Clare Walton, et al.
Frontiers in Neurology|January 8, 2024
Predictors of treatment switching in the Big Multiple Sclerosis Data NetworkTim Spelman, Melinda Magyari, Helmut Butzkueven, et al.
Pageof 7